Buprenorphine derivatives and uses thereof

Details Buprenorphine derivatives and uses thereof Buprenorphine derivatives and uses thereof

2011-06-21

2011-06-21

Aulakh, Charanjit (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S039000

Reexamination Certificate

active

07964610

ABSTRACT:
Ester derivatives of the phenolic hydroxyl group of buprenorphine can be used in the treatment of opiate dependency and/or moderate to severe pain. The esters have an enhanced bioavailability, an enhanced duration of action, and a reduced abuse potential.

REFERENCES:
patent: 4668685 (1987-05-01), Shami
patent: 4935428 (1990-06-01), Lewis
patent: 5750534 (1998-05-01), Yoa-Pu
patent: 5817665 (1998-10-01), Dante
patent: 5849915 (1998-12-01), Kim
patent: 5985880 (1999-11-01), Chang
patent: 6004969 (1999-12-01), Hu
patent: 6225321 (2001-05-01), Hu
patent: 6300332 (2001-10-01), Chang
patent: 6696088 (2004-02-01), Oshlack
patent: 6716449 (2004-04-01), Oshlack
patent: 7195882 (2007-03-01), Root
patent: 7220842 (2007-05-01), Zheng
patent: 2004/0033253 (2004-02-01), Shevchuk
patent: 2004/0151670 (2004-08-01), Blondino
patent: 2005/0075361 (2005-04-01), Wang
patent: 2005/0085440 (2005-04-01), Birch
patent: 2005/0142072 (2005-06-01), Birch
patent: 2005/0152843 (2005-07-01), Bartholomaus
patent: 2005/0154002 (2005-07-01), Crooks
patent: 2005/0186139 (2005-08-01), Bartholomaus
patent: 2005/0191244 (2005-09-01), Bartholomaus
patent: 2005/0214223 (2005-09-01), Bartholomaus
patent: 2006/0287244 (2006-12-01), Chandran
patent: 2007/0140975 (2007-06-01), Baichwal
patent: 1131059 (1999-11-01), None
patent: 1422230 (2002-11-01), None
patent: 1558221 (2003-10-01), None
Imoto, “Transdermal Prodrug Concepts: Permeation of Buprenorphine and Its Alkyl Esters through Hairless Mouse Skin and Influence of Vehicles”Biol. Pharm. Bull.(1996), vol. 19, pp. 263-267.
Jasinski and Preston, “Laboratory Stuides of Buprenorphine in Opioid Abusers”, Buprenorphine, Ed. A Cowan, JW Lewis, Wiley-Lis, (1995), pp. 189-211.
Stinchcomb, “A Solubility and Related Physicochemical Property Comparison of Buprenorphine and Its 3-Alkyl Esters”,Pharm. Res.(1995), vol. 12, pp. 1526-1529.
Stinchcomb, “Permeation of Buprenorphine and Its 3-Alkyl-Ester Prodrugs Through Human Skin”,Pharm. Res.(1996), vol. 13, pp. 1519-1523.
International Search Report, Application No. PCT/GB2007/001120, dated Jul. 30, 2007.
Written Opinion of the International Searching Authority, Application No. PCT/GB2007/001120, dated Jul. 30, 2007.

Affiliated with

Also associated with

Rating

Buprenorphine derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Buprenorphine derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buprenorphine derivatives and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2723450